How To Use HCPCS Code C9144

HCPCS code C9144 describes the injection of bupivacaine (posimir) at a dosage of 1 mg. This code is used to identify the administration of this specific medication and is typically used in the context of enteral supplementation that is not otherwise classified. In this article, we will explore the details of HCPCS code C9144, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C9144?

HCPCS code C9144 is used to identify the injection of bupivacaine (posimir) at a dosage of 1 mg. This code specifically pertains to enteral supplementation that is not otherwise classified. It is important to note that this code should only be used for the administration of bupivacaine (posimir) and not for any other medications or procedures.

2. Official Description

The official description of HCPCS code C9144 is “Injection, bupivacaine (posimir), 1 mg.” This description accurately reflects the purpose and dosage of the medication being administered. The short description for this code is “Enteral supp not otherwise c,” which further emphasizes that it is used for enteral supplementation that is not otherwise classified.

3. Procedure

1. Prepare the necessary equipment and supplies for the injection.
2. Verify the patient’s identity and confirm the need for bupivacaine (posimir) administration.
3. Ensure proper hand hygiene and don personal protective equipment.
4. Select an appropriate injection site and clean it with an antiseptic solution.
5. Prepare the bupivacaine (posimir) solution according to the manufacturer’s instructions.
6. Using a sterile syringe and needle, draw up the prescribed dosage of bupivacaine (posimir).
7. Administer the injection into the selected site using the appropriate technique.
8. Dispose of used needles and syringes in a sharps container.
9. Document the administration of bupivacaine (posimir) in the patient’s medical record.

4. When to use HCPCS code C9144

HCPCS code C9144 should be used when administering bupivacaine (posimir) at a dosage of 1 mg for enteral supplementation that is not otherwise classified. It is important to ensure that the patient meets the specific eligibility criteria for this code and that the administration of bupivacaine (posimir) is medically necessary.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9144, healthcare providers should ensure that the following documentation requirements are met:

• Documentation of the patient’s medical condition or need for enteral supplementation.
• Documentation of the dosage and administration of bupivacaine (posimir).
• Documentation of any complications or adverse reactions, if applicable.

Providers should also follow the appropriate billing guidelines and submit the necessary supporting documentation to ensure accurate and timely reimbursement for the service.

6. Historical Information and Code Maintenance

HCPCS code C9144 was added to the Healthcare Common Procedure Coding System on January 01, 1985. Since its addition, there have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. It is important to note that this code has an effective date of January 01, 1996, and has remained unchanged since then.

7. Medicare and Insurance Coverage

HCPCS code C9144 is covered by Medicare and other insurance carriers. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code for this code is A, which means it is not applicable as HCPCS priced under one methodology. Providers should refer to the Medicare Carriers Manual Reference Section Number 2130 for specific guidance on billing and reimbursement for HCPCS code C9144.

8. Examples

Here are five examples of when HCPCS code C9144 should be billed:

1. A patient with a history of chronic pain receives an enteral supplementation of bupivacaine (posimir) at a dosage of 1 mg to manage their symptoms.
2. A post-operative patient requires enteral supplementation of bupivacaine (posimir) at a dosage of 1 mg to provide localized pain relief.
3. A patient with a severe injury receives an enteral supplementation of bupivacaine (posimir) at a dosage of 1 mg as part of their pain management plan.
4. A patient undergoing a medical procedure requires enteral supplementation of bupivacaine (posimir) at a dosage of 1 mg to minimize discomfort during the procedure.
5. A patient with a chronic medical condition receives regular enteral supplementation of bupivacaine (posimir) at a dosage of 1 mg to improve their quality of life.